MyBlueDotsPureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) MyBlueDots4 weeks ago01 mins BOSTON–(BUSINESS WIRE)–PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots9 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots9 hours ago 0